HIF-1, an important regulator in potential new therapeutic approaches to ischemic stroke
Neurochemistry International · 2023-11 · 170 · 105605
DOI: 10.1016/j.neuint.2023.105605 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurochemistry International, 2023-11. Verfasst von Sneha Vatte und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, 440033, India. Electronic address: snehavatte28@gmail.…. Hauptthemen laut MEDLINE: Ischemic Stroke, Stroke. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 150 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Ischemic stroke is a leading cause of disability and mortality worldwide due to the narrow therapeutic window of the only approved therapies like intravenous thrombolysis and thrombectomy. Hypoxia inducible factor-1α (HIF-1α) is a sensitive regulator of oxygen homeostasis, and its expression is rapidly induced after hypoxia/ischemia. It plays an extensive role in the pathophysiology of stroke by regulating multiple pathways including glucose metabolism, angiogenesis, neuronal survival, neuroinflammation and blood brain barrier regulation. Here, we give a brief overview of the HIF-1α-targeting strategies currently under investigation and summarise recent research on how HIF-1α is regulated in various brain cells, including neurons and microglia, at various stages in ischemic stroke. The roles of HIF-1 in stroke varies with ischemic time and degree of ischemia, are still up for debate. More focus has been placed on prospective HIF-1α targeting drugs, such as HIF-1α activator, HIF-1α stabilizers, and natural compounds. In this review, we have highlighted the regulation of HIF-1α in the novel therapeutic approaches for treatment of stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, 440033, India. Electronic address: snehavatte28@gmail.com.
- Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, 440033, India. Electronic address: ugale.rajesh@gmail.com.
Zitieren
APA
Vatte, S., & Ugale, R. (2023). HIF-1, an important regulator in potential new therapeutic approaches to ischemic stroke. Neurochemistry International, 170, 105605. https://doi.org/10.1016/j.neuint.2023.105605
Vancouver
Vatte S, Ugale R. HIF-1, an important regulator in potential new therapeutic approaches to ischemic stroke. Neurochemistry International. 2023;170:105605. doi:10.1016/j.neuint.2023.105605
BibTeX
@article{Vatte2023,
author = {Vatte, Sneha and Ugale, Rajesh},
title = {HIF-1, an important regulator in potential new therapeutic approaches to ischemic stroke},
journal = {Neurochemistry International},
year = {2023},
volume = {170},
pages = {105605},
doi = {10.1016/j.neuint.2023.105605}
}
EUVIMED